Hypertension, Renovascular
10
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
10.0%
1 terminated out of 10 trials
75.0%
-11.5% vs benchmark
30%
3 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis--a Multicenter Study
Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension
Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery
Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis
Endovascular Therapy for Renal Artery Stenosis in China
Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
Renal Atherosclerotic Revascularization Evaluation: RAVE Study